Changsheng Xing

Changsheng Xing |Clyto Access

Center for Inflammation and Epigenetics, HMHRI, USA


Expertise: Prostate cancer, cell proliferation, urologic oncology, signaling pathways, breast cancer


Changsheng Xing is a postdoctoral fellow in Dr. Rong-Fu Wang's group at Houston Methodist Research Institute. He obtained his Ph.D. in Genetics and B.S. in Biosciences from the College of Life Sciences, Nankai University, China. He worked as a visiting scholar for School of Medicine, Emory University, USA. His major projects include:Development of novel cancer c with antigen-specific TCR-engineered T cells, Role of Map3k7 in regulating innate immune signaling, acute colitis and colon cancer, Function of specific gut microbiota composition in preventing colitis and colon cancer, Anti-tumor immunity of functionally modified Treg cells.

His research interests focus on the molecular mechanisms of cancer initiation and development, the cancer-related immune responses, and cancer immunotherapy.

Related Journals & Conferences :

Current Research and Therapy in Cancer